Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia
Author
McCubrey, James A.
Date
2015-03-02
Citation:
APA:
McCubrey, James A.. (March 2015).
Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia.
Oncotarget,
(6:9), p.6597-6610. Retrieved from
http://hdl.handle.net/10342/9587
MLA:
McCubrey, James A..
"Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia". Oncotarget.
6:9. (6597-6610.),
March 2015.
May 23, 2022.
http://hdl.handle.net/10342/9587.
Chicago:
McCubrey, James A.,
"Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia," Oncotarget 6, no.
9 (March 2015),
http://hdl.handle.net/10342/9587 (accessed
May 23, 2022).
AMA:
McCubrey, James A..
Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia. Oncotarget.
March 2015;
6(9)
6597-6610. http://hdl.handle.net/10342/9587. Accessed
May 23, 2022.
Collections